Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia

ClinicalTrials.gov ID: NCT00105508

Public ClinicalTrials.gov record NCT00105508. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 11:55 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Placebo-controlled, Multicenter, Multinational Phase III Study to Evaluate the Safety and Efficacy of Sarizotan HCl 1 mg b.i.d. in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine if Sarizotan HC1 1 mg b.i.d. (taken twice a day) is effective in the treatment of dyskinesia associated with dopaminergic treatment of Parkinson's disease (PD).

Study identification

NCT ID
NCT00105508
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
EMD Serono
Industry
Enrollment
506 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
30 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2004 (Actual)
Primary completion
Feb 28, 2006 (Actual)
Completion
Feb 28, 2006 (Actual)
Last update posted
Jul 26, 2018

2004 – 2006

United States locations

U.S. sites
31
U.S. states
21
U.S. cities
29
Facility City State ZIP Site status
Not listed Birmingham Alabama 35233 —
Not listed Huntsville Alabama 35801 —
Not listed La Jolla California 92037 —
Not listed Oxnard California 93030 —
Not listed Sacramento California 95817 —
Not listed Englewood Colorado 80113 —
Not listed Danbury Connecticut 06810 —
Not listed Farmington Connecticut 06030-1840 —
Not listed Jacksonville Florida 32209 —
Not listed Jacksonville Florida 32216 —
Not listed Maitland Florida 32751 —
Not listed St. Petersburg Florida 33703 —
Not listed Decatur Georgia 30033 —
Not listed Chicago Illinois 60611-3078 —
Not listed Springfield Illinois 62702 —
Not listed Des Moines Iowa 50309 —
Not listed New Orleans Louisiana 70112 —
Not listed Scarborough Maine 04074 —
Not listed Boston Massachusetts 02215 —
Not listed Southfield Michigan 48034 —
Not listed Edison New Jersey 08818 —
Not listed New Hyde Park New York 11040 —
Not listed New Hyde Park New York 12401 —
Not listed New York New York 10016 —
Not listed Durham North Carolina 27705 —
Not listed Oklahoma City Oklahoma 73104 —
Not listed Pittsburgh Pennsylvania 15213 —
Not listed Brentwood Tennessee 37027 —
Not listed South Ogden Utah 84403 —
Not listed Spokane Washington 99204 —
Not listed Milwaukee Wisconsin 53233 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00105508, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 26, 2018 · Synced Nov 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00105508 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →